NM_000626.4(CD79B):c.67+3A>G AND Agammaglobulinemia 6, autosomal recessive

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Nov 22, 2021
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV001939314.3

Allele description [Variation Report for NM_000626.4(CD79B):c.67+3A>G]

NM_000626.4(CD79B):c.67+3A>G

Genes:

CD79B:CD79b molecule [Gene - OMIM - HGNC]
GH-LCR:growth hormone locus control region [Gene]

Variant type:

single nucleotide variant

Cytogenetic location:

17q23.3

Genomic location:

Preferred name:

NM_000626.4(CD79B):c.67+3A>G

HGVS:

NC_000017.11:g.63932192T>C
NG_007368.1:g.5153A>G
NG_042788.1:g.15100T>C
NM_000626.4:c.67+3A>GMANE SELECT
NM_001039933.3:c.67+3A>G
NM_001329050.2:c.67+3A>G
NM_021602.4:c.67+3A>G
LRG_43:g.5153A>G
NC_000017.10:g.62009552T>C

Links:

dbSNP: rs1335363614

NCBI 1000 Genomes Browser:

rs1335363614

Molecular consequence:

NM_000626.4:c.67+3A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001039933.3:c.67+3A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001329050.2:c.67+3A>G - intron variant - [Sequence Ontology: SO:0001627]
NM_021602.4:c.67+3A>G - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:: Agammaglobulinemia 6, autosomal recessive (AGM6)
Synonyms:: AGAMMAGLOBULINEMIA 6; AGAMMAGLOBULINEMIA, AUTOSOMAL RECESSIVE, DUE TO CD79B DEFECT
Identifiers:: MONDO: MONDO:0012987; MedGen: C3150207; OMIM: 612692

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV002226412	Invitae	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Nov 22, 2021)	germline	clinical testing	PubMed (3) [See all records that cite these PMIDs] 17576681, 9536098, 28492532

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV002226412

Invitae

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Nov 22, 2021)

germline

clinical testing

PubMed (3)
[See all records that cite these PMIDs]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Aberrant 5' splice sites in human disease genes: mutation pattern, nucleotide structure and comparison of computational tools that predict their utilization.

Buratti E, Chivers M, Královicová J, Romano M, Baralle M, Krainer AR, Vorechovsky I.

Nucleic Acids Res. 2007;35(13):4250-63. Epub 2007 Jun 18.

PubMed [citation]

PMID:: 17576681
PMCID:: PMC1934990

Statistical features of human exons and their flanking regions.

Zhang MQ.

Hum Mol Genet. 1998 May;7(5):919-32.

PubMed [citation]

PMID:: 9536098

See all PubMed Citations (3)

Details of each submission

From Invitae, SCV002226412.3

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (3)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Experimental studies and prediction algorithms are not available or were not evaluated, and the effect of this variant on mRNA splicing is currently unknown. This variant has not been reported in the literature in individuals affected with CD79B-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change falls in intron 1 of the CD79B gene. It does not directly change the encoded amino acid sequence of the CD79B protein. It affects a nucleotide within the consensus splice site.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Feb 20, 2024

ClinVar

Relating variation to medicine